RecruitingNot ApplicableNCT06978231

Effect of Same-session EUS on ERCP in Pancreaticobiliary Diseases

Effect of Same-session Endoscopic Ultrasonography on Endoscopic Retrograde Cholangiopancreatography in Pancreaticobiliary Diseases: A Randomized Controlled Trial


Sponsor

Qilu Hospital of Shandong University

Enrollment

214 participants

Start Date

Jun 10, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This is a single-center randomized controlled trial. Eligible subjects meeting inclusion/exclusion criteria will be randomized 1:1 to EUS+ERCP group or ERCP group. Clinical data and patient-reported outcomes are regularly collected at baseline and during follow-up periods. A comparative analysis was conducted to assess the impact of same-session EUS on ERCP strategy modification between two groups, utilizing a structured questionnaire.Secondarily, the safety and efficacy of same-session EUS will be comprehensively evaluated by comparing complication rates, technical success rate and hospitalization costs, length of stay, and radiation exposure between groups.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Patients aged ≥18 years;
  • Patients with pancreaticobiliary diseases definitively indicated for ERCP (as confirmed by HBP Specialists );
  • No prior history of ERCP;
  • No pancreaticobiliary EUS examinations within the preceding 3 months.

Exclusion Criteria9

  • Patients with clinically confirmed malignant lesions deemed surgically unresectable by multidisciplinary evaluation and requiring pathological diagnosis exclusively for chemotherapy/radiotherapy guidance;
  • Patients with confirmed diagnosis requiring only palliative biliary/pancreatic stent placement for obstructive jaundice ;
  • Patients with anatomical alterations or surgical history affecting EUS feasibility;
  • Severe systemic illness including severe hepatic, renal, cardiopulmonary and cerebrovascular diseases with high risk for endoscopic procedures;
  • Contraindication to iodinated contrast media (allergy or renal impairment preventing ERCP);
  • Pregnancy or lactation;
  • Patients with severe coagulopathy;
  • Declined informed consent;
  • Severe psychiatric disorder/non-cooperation precluding safe procedure.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREEUS+ERCP

EUS were performed during the same session with ERCP under continuous sedation/anesthesia

PROCEDUREERCP

Only ERCP was performed in the control group


Locations(1)

Qilu Hospital of Shandong University

Jinan, Shandong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06978231